Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-06-10

FDA Approved: OXALIPLATIN — Original Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

The FDA granted approval of the original application for oxaliplatin from Fresenius Kabi USA, LLC, enabling its generic production and sale.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OXALIPLATIN (Oxaliplatin)

Snippet

ORIG AP for OXALIPLATIN (OXALIPLATIN)